Giancarlo O.
- Country
- Italy
- Department
- U.O.C Otorinolaringoiatria
Research Overview
- Long‑Term Safety and Tolerability of Subcutaneous Itepekimab in Adults with Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyps: Double‑Blind Extension Study
- Efficacy and Safety Evaluation of Lebrikizumab in Chronic Rhinosinusitis with Nasal Polyps on Intranasal Corticosteroids: A Phase 3 Randomized Controlled Trial
- Phase 3b Multicenter Study on Tezepelumab for Symptom Modulation in Chronic Rhinosinusitis with Nasal Polyposis
Data & Insights
Has run more than one trial at 59 of 139 partner sites.
Specializations
Rhinology and Sinonasal Disorders
The investigator specializes in treating chronic rhinosinusitis with nasal polyps (CRSwNP), focusing on innovative therapeutic approaches for patients with persistent sinonasal conditions.
- Nasal Polyp Management
- Intranasal Corticosteroid Therapy
- Sinonasal Symptom Assessment
Their work includes evaluation of nasal congestion severity and endoscopic polyp scoring.
Biological Therapeutics
The investigator works with advanced monoclonal antibody treatments for inflammatory airway conditions, including lebrikizumab, tezepelumab, and itepekimab.
- IL-33 Pathway Targeting
- Inflammatory Mediator Modulation
- Biological Response Assessment
Their expertise extends to evaluating novel biological agents for nasal polyposis treatment.
Clinical Outcomes Assessment
The investigator utilizes comprehensive patient-reported outcome measures to evaluate treatment efficacy in sinonasal conditions.
- Nasal Polyposis Symptom Diary (NPSD)
- SNOT-22 Assessment
- Quality of Life Evaluation
Their research incorporates validated assessment tools for measuring therapeutic response in nasal polyp treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.